Prevalence of Intestinal Parasitic Infections in Patients With Irritable Bowel Syndrome
NCT ID: NCT05830370
Last Updated: 2023-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-05-01
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
B. hominis is one of the most common human intestinal protozoa in both developing and developed countries. some studies have reported a significant association between the parasitic infections, especially Blastocystis, and IBS.Cryptosporidium has been reported in IBS patients, with the onset of gastrointestinal symptoms after an acute episode of cryptosporidiosis despite recovery and parasite clearance.Numerous studies have been conducted to evaluate the association between the parasitic infections and IBS.
Aim of the work:
To detect prevalence of intestinal parasitic infections in irritable bowel syndrome patients in sohag.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome
NCT04760600
Prevalence of Irritable Bowel Syndrome Among Egyptian Medical Students
NCT07033936
Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea
NCT02003807
Prevalence of Irritable Bowel Syndrome in Medical Students Africa
NCT06097598
Primary Headaches and Irritable Bowel Syndrome.
NCT05057533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
case
patients complaining of symptoms of IBS fulfilling the Rome criteria , such as abdominal discomfort, diarrhea, and constipation, bloating with any age \& sex groups from different locations.
No interventions assigned to this group
control
healthy individuals not suffering from IBS symptoms such as abdominal discomfort, diarrhea, and constipation, bloating.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nada Mahmoud Ahmed
Demonstrator at medical parasitology department.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine Sohag University
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-23-04-23MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.